Prot# GE-122-020: AdreView™ Myocardial Imaging for Risk Evaluation – A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients with 30%≤LVEF≤35%. ADMIRE-ICD